Gene Therapy for Childhood Diseases: Everything You Need to Know
Gene therapies can replace the single nonworking gene, so that it can now provide its necessary function
If you’ve spent any time reading up on or living life with a rare condition, chances are you’ve come across the terms “genetic disorder,” and “gene therapy.” But what exactly do they mean? And what differentiates them from other diseases and treatments?
A genetic disease is caused by nonworking or missing genes. Scientists recently found that genes may play a part in many diseases. Genetic diseases can be the result of a mutation in one gene or multiple genes. Some mutations are inherited from one or both parents. Other diseases are caused by mutations that occur randomly, or due to environmental exposure (such as cigarette smoke—which causes cancer).
Genetic diseases that are the result of a single, nonworking, or missing gene make an easier target for gene therapies. These therapies can replace the single nonworking gene so that it can now provide its necessary function.
Some of the one-gene group of rare genetic disorders being studied for gene therapies are:
Danon disease - caused by changes (mutations) in the LAMP2 gene, so waste materials build up inside heart muscle cells, causing the cells to get larger and die. Over time, this can make the heart become enlarged and weaker.
Cystic fibrosis — caused by a mutation in the CFTR gene, which makes the body unable to produce a specific protein essential for free-flowing mucous. A thick sticky mucous builds up in the lining of the lungs.
Duchennes Muscular Dystrophy — the result of a mutation of the DMD gene, necessary for producing a protein responsible for muscle development.
Gauchers Disease — caused by one gene, GBA1, but can have many different mutations, and therefore there are many different types of the disease. There are two categories of Gaucher disease: those that affect the nervous system (Types 2 & 3) and those that do not (Type 1).
Hemophilia — there is a type A and type B, which are both caused by a mutation in either the F8 or the F9 genes. Because of this absent gene, a person with hemophilia is missing an important element needed for their blood to clot after an injury.
Sanfilippo Syndrome (MPS IIIa) — caused by a non-functional or missing SGSH gene which produces an enzyme that’s essential for processing sugar molecules. This causes a buildup in many areas of the body, especially the brain, leading to neurological and developmental issues.
Spinal Muscle Atrophy (SMA) — caused by a missing or non-functional SMN1 gene responsible for a protein needed by the nerves that are connected to muscle function (motor neurons). Over time, these motor neurons die, and the muscles required for walking, talking, eating, and breathing eventually don’t work.
Clinical studies for gene therapies are in development for many orphan diseases. Some of these studies are specifically looking for young children, and are being conducted in centers that specialize in the study of genetic diseases in children.
There are gene therapy studies for rare genetic blood diseases, metabolic diseases, neurological and and for neuromuscular disorders. Although gene therapies do not cure the disease, they do address the root cause of the disorder. They are also given as a one-time treatment, which can “fix” the problem caused by the missing gene. However, since most gene therapies are relatively new, how long the effect, or the “fix,” will last is still unknown.
Centers and researchers who are involved in clinical studies of gene therapies are highly knowledgeable about genetic diseases and gene therapies and are likely to have the most experience in using them.
If you are interested in seeing if there are any gene therapy studies available for your condition, contact Know Rare.
Sources:
NIH National Human Genome Research Institute: https://www.genome.gov/Clinical-Research/Current-NHGRI-Clinical-Studies
https://medlineplus.gov/genetics/condition/danon-disease/#causes
If you or your loved one is living with Danon disease and would like to learn about the latest research opportunities, please fill out this quick form:
Latest from Know Rare
From prenatal uncertainty and postpartum anxiety to therapy, grief, and hope, a mother shares her experience raising a child with a rare disease, navigating the healthcare system, finding community, and learning to embrace a different—but deeply meaningful—path as a parent.
A Danon disease study, led by researcher Dr. Barry Greenberg and published in the New England Journal of Medicine, wins an award! The study focuses on gene therapy as a potential treatment option for Danon disease. The study showed early signs that gene therapy may help the hearts of people with Danon disease.
A poster, presented at the European Hematology Association meeting in June, described a study that looked at tiredness (fatigue) in adults with immune thrombocytopenia (ITP). Researchers wanted to see if fatigue was related to bleeding or other health test results.
Lucky Shanmugan was recently featured in Porter Ranch Living, his local magazine, for Father’s Day: in his interview, Lucky talks about Osteogenesis Imperfecta, a rare genetic or heritable disorder of the connective tissue, and the incredible journey towards his official diagnosis.
Here are 9 things Chris Anselmo wishes someone had told him after his rare disease diagnosis.
A family’s hardships and resilience in finding answers and getting a diagnosis for their child, after numerous tests, brain biopsies, and hospitalizations. And the relief but also grief in finally putting a name to the rare disease that affects their child: BCL11B-related disorder.
The Danon Foundation boldly empowers people living with Danon disease, providing trusted information, resources and support to help navigate life, from diagnosis to treatment.
For many families, caregiving for a child with a rare or medically complex condition is a full-time job. The problem is, it’s a job with no training, no time off, and no clear job description. If you’re looking for the light at the end of the tunnel, you don’t have to search alone. Check out some of Paige’s favorite resources.
For most of celiacs, despite months on a strict GF diet, energy stays low and blood work reveals nutrient deficiencies. The lesson? A "gluten-free" label isn't a health guarantee—just a guarantee you'll pay more.
If you’ve been told you have seronegative NMOSD, there’s nearly 50/50 chance you have a different antibody causing your symptoms –MOG antibody.
Therapy Near Me is a nationwide mental health service based in Australia, providing easy access to psychologists, counsellors, behaviour support practitioners and social workers.
At the annual Kidney Week of the American Society of Nephrologists (ASN), the world’s largest kidney healthcare professional organization, new advances in research were highlighted. Over $35 million has been invested in research with the ASN, and there are many treatments in development for IgA Nephropathy (IgAN), with researchers actively investigating more than 20 different drugs.
When I was diagnosed with celiac disease, I thought avoiding bread and pasta would be enough. I quickly learned that living truly gluten-free is far more complex, and I'm sharing my experience to help newly diagnosed individuals understand what lies ahead.
Retinopathy is an eye problem that many people with Danon disease have. It can cause dark spots in the outer part of the eye, blurry or worse vision, and unusual test results on an eye exam. Sometimes these eye changes show up before heart problems, so an eye check can help find the disease early.
A heartfelt story about a mother who found purpose and strength among the tragedy of losing a child diagnosed with an ultra rare genetic disorder.
Kaya Girl Legacy, Inc. is a Florida-based nonprofit founded in memory of Kaya Humbert, a beautiful baby girl born with Sphingosine Phosphate Lyase Insufficiency Syndrome (SPLIS), one of 46 known cases worldwide. The foundation is dedicated to empowering families with knowledge about their genetic health and advocating for early access to genetic testing and rare disease awareness.
A prose poem by Jim Kuhn, a rare warrior living with Sarcoidosis, a rare inflammatory disease.
Rare Mom Laura shares how her family’s prep for Halloween turned into a burst of familial love and creativity, as they all worked together in designing and building a costume for Alden, her medically complex son.
Instead of starting with a newly discovered drug compound, PCOR is a type of research that starts by turning to patients and caregivers and asking, What matters most to you? What questions do we want answered? What symptoms do we wish were better managed? What keeps us up at night?
Four years ago, Michael Grivas’ life suddenly changed when he learned that he had Brugada Syndrome, a genetic disorder in which the electrical activity of the heart is abnormal due to channelopathy. Learn more about his story.
Fatigue is a very common and often debilitating symptom of IgAN. It is linked to disease progression and reduced kidney function, but other factors like inflammation, anemia, and mental health also play a role. In a 2025 study, the majority of patients with IgAN reported fatigue, and patients with more severe proteinuria and lower kidney filtration rates (eGFR) experienced worse fatigue.
Why is it so hard to accept help? Humans often associate help with weakness and loss of independence and control. However, if we reframe our thoughts, accepting help can be viewed as a form of empowerment: showing vulnerability and trusting someone to help us requires great strength.
There is so much mental load with having a rare disease. Rare Human Lindsay shares there are things she does not care about anymore, as she manages rare disease symptoms, specialists, and clinical trials.
Rare Human Lindsay shares her "silver linings." It's not 'what doesn't kill you makes you stronger,' instead it's what doesn't kill you makes you braver. She shares that she has found deeper connections with others, improved her ability to ask for and accept help, and not been as afraid of the word "no."
Journalist and rare disease advocate Lindsay Guentzel breaks down why clinical trials are a lifeline for the rare disease community. With only 5% of known rare diseases having an FDA-approved therapy, trials often represent the only path toward treatment, progress, and hope.
Lindsay was diagnosed with dermatomyositis a couple of years ago. Since then, she has undergone more than 350 doctor appointments, 250+ hours of infusions, 10+ ER visits, while juggling insurance approvals, rides, and her pain and fatigue.
Rare Human Lindsay is in the midst of her first clinical trial for dermatomyositis, a rare inflammatory disease that primarily affects the skin and muscles. So far, she has learned so much about the process and is eager to share some of her insights with the rare disease community.